Kentucky Lawmakers Criticize Trump Election Fraud Claims as Professor Sues Northwestern Over Tenure

Republican members of Kentucky's federal delegation are pushing back hard against President Donald Trump's claims of widespread election fraud. They called his speech "absurd" and "ridiculous," according to Kentucky.com. Trump announced he had declassified documents he says reveal problems in the 2018 and 2020 elections, including alleged interference by China. He offered no specific evidence that either election was actually changed.
The same week brought two other major stories: a Northwestern University professor suing his school over denied tenure, and the U.K. approving a new daily cholesterol pill, according to News Observer.
Trump's speech on election fraud drew rare criticism from members of his own party in Kentucky. Several Republican lawmakers called the speech "absurd" and "ridiculous," according to Sun Herald. Trump claimed declassified documents show China interfered in the 2018 and 2020 elections. He did not show specific proof that votes were changed or that results were altered.
The pushback is notable because Republicans rarely break with Trump publicly. Charlotte Observer reported that the Kentucky delegation's sharp words signal growing frustration over continued focus on past elections. Critics say relitigating 2020 distracts from current policy work.
A Northwestern University professor has filed a federal lawsuit claiming the school denied him tenure because of his pro-Palestinian activism and on-campus speech, according to Sacramento Bee. The lawsuit names several high-profile defendants. They include U.S. Rep. Tim Walberg, Secretary of Education Linda McMahon, acting Attorney General Todd Blanche, and Health Secretary Robert F. Kennedy Jr.
The case raises major questions about free speech and academic freedom at American universities. Tenure is a permanent job protection that professors earn after years of review. The professor argues his views on Palestinian issues — not his academic record — cost him that protection. The lawsuit is a federal case, meaning it could set a broad legal precedent.
The U.K. Food and Drug Administration approved a new daily pill designed to lower cholesterol, according to News Observer. Health officials say the pill is easier to take than many existing treatments. They expect more patients to stick with the medication compared to older options that require injections or complex routines. Higher compliance means better health outcomes for heart patients.
High cholesterol is a leading risk factor for heart disease and stroke, two of the world's top killers. Current treatments include statins, taken as daily pills, and newer injectable drugs called PCSK9 inhibitors. The new pill could offer strong cholesterol-lowering effects in a simple format that more patients will actually use every day, Sun Herald reported.
Publishers
5
Articles
5
Reach
5